Overview
Dr. Topalian is a physician-scientist whose studies of anti-tumor immunity have been foundational in developing cancer immunotherapy. She has published over 160 original research articles and reviews in this area and is one of the most highly cited researchers in the biomedical field. She received her medical and scientific training at Tufts University School of Medicine, Thomas Jefferson University Hospital, Children’s Hospital of Philadelphia and the National Cancer Institute. She joined the Johns Hopkins Kimmel Cancer Center in 2006 as the inaugural director of its Melanoma Program. Dr. Topalian is credited with advancing the clinical development of anti-PD-1 immunotherapy, and her work is widely recognized. She was named one of Nature’s 10 in 2014, and received the Karnofsky Award from ASCO in 2015, the Taubman Prize in 2016, the NCI’s Rosalind E. Franklin Award in 2018, the American Academy of Dermatology’s Gruber Memorial Cancer Research Award in 2020, and the Award for Distinguished Research in the Biomedical Sciences from the Association of American Medical Colleges in 2021 for landmark discoveries in cancer immunotherapy. Dr. Topalian was elected to the National Academy of Medicine in 2017, and to the American Association for Cancer Research Academy in 2022. Her work has opened new avenues of scientific investigation and established immunotherapy as a pillar of oncology.
Dr. Topalian is highly rated in 3 conditions, according to our data. Her top areas of expertise are Merkel Cell Carcinoma, Melanoma, Neuroendocrine Tumor, and Anal Cancer.
Her clinical research consists of co-authoring 78 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Residency
Specialties
Licenses
Fellowships
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
Locations
Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Skip Viragh Outpatient Cancer Center
Richard Burkhart, M.D., is an Associate Professor of Surgery at The Johns Hopkins Hospital with a focus on complex minimally-invasive surgery and research for cancers of the pancreas, liver and bile ducts. Dr. Burkhart received his medical degree from Boston University and completed his surgical residency and research fellowships at the Thomas Jefferson University Hospital in Philadelphia and the Cold Spring Harbor Laboratories. He is a member of several professional organizations, including the American Association of Cancer Research, the American College of Surgeons, the Society of Surgery for the Alimentary Tract, the Pancreas Club, and the Society of Surgical Oncology. Outside the operating room, Dr. Burkhart heads a multidisciplinary laboratory team dedicated to bringing next-generation precision medicine approaches into the routine clinical care of patients that we serve. He has a particular research interest in using personalized models of pancreas cancer, made from tumor during and immediately after surgical resection, to select the best chemotherapy for each patient to support long-term survival and improve rates of disease cure. The laboratory team, funded in part by the National Institutes of Health, the National Cancer Institute, the Lustgarten Foundation and Stand Up to Cancer, is also thankful to the many patients who have supported the work through philanthropic gift. Dr. Burkhart is highly rated in 15 conditions, according to our data. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Familial Pancreatic Cancer, Pancreatectomy, and Pancreaticoduodenectomy.
David Euhus is a Surgical Oncologist and a General Surgeon in Baltimore, Maryland. Dr. Euhus is highly rated in 9 conditions, according to our data. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, Mastectomy, and Lymphadenectomy.
St Paul Place Specialists, Inc.
Armando Sardi is a Surgical Oncologist in Baltimore, Maryland. Dr. Sardi is highly rated in 26 conditions, according to our data. His top areas of expertise are Pseudomyxoma Peritonei, Colorectal Cancer, Familial Colorectal Cancer, Ureteroscopy, and Hernia Surgery. Dr. Sardi is currently accepting new patients.
Frequently Asked Questions about Dr. Suzanne L. Topalian
How do I make an appointment with Dr. Suzanne L. Topalian?
You can book an appointment with Dr. Suzanne L. Topalian by calling their office at 410-955-5000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Suzanne L. Topalian a top-rated expert for Merkel Cell Carcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Suzanne L. Topalian is classified as an Distinguished expert for Merkel Cell Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Suzanne L. Topalian specialize in?
While Dr. Suzanne L. Topalian is a Surgical Oncology, they have specific expertise in Merkel Cell Carcinoma, Melanoma, and Neuroendocrine Tumor. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Surgical Oncology.
Does Dr. Suzanne L. Topalian participate in research or clinical trials?
Yes. Dr. Suzanne L. Topalian has published 78 articles and abstracts on conditions like Merkel Cell Carcinoma. You can view a list of Dr. Suzanne L. Topalian's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Suzanne L. Topalian accept my insurance?
Dr. Suzanne L. Topalian accepts most major insurance plans, including Aetna and CareFirst. We recommend calling the office directly at 410-955-5000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- MelanomaDr. Topalian isDistinguished. Learn about Melanoma.
- Merkel Cell CarcinomaDr. Topalian isDistinguished. Learn about Merkel Cell Carcinoma.
- Advanced
- Neuroendocrine TumorDr. Topalian isAdvanced. Learn about Neuroendocrine Tumor.
- Experienced
- Anal CancerDr. Topalian isExperienced. Learn about Anal Cancer.